IONIS PHARMACEUTICALS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
IONS$28.19-9.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net loss | $(381,387) | $(453,897) | $(366,286) |
| Unrealized gains on debt securities, net of tax | 4,828 | 2,107 | 24,484 |
| Currency translation adjustment | 702 | (273) | 351 |
| Comprehensive loss | $(375,857) | $(452,063) | $(341,451) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.